🇺🇸
United States · US · US:50090-7077_cc399f8e-7e57-48bd-993c-2104a4b1acf4
TRESIBA
In shortageUNIISPLATC A10AE06
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerA-S Medication Solutions
CountryUS (United States)
ATC codeA10AE06
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1150090707705 SYRINGE, PLASTIC in 1 CARTON (50090-7077-0) / 3 mL in 1 SYRINGE, PLASTIC
Annotations
UNII (FDA Substance ID)
54Q18076QB
INSULIN DEGLUDEC
RxCUI 1670007
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension
Raw payload (JSON)
{
"unii": {
"unii": "54Q18076QB",
"rxcui": "1670007",
"inchikey": null,
"display_name": "INSULIN DEGLUDEC",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"e8ccd2f4-6ba9-4839-87f8-4742dc9b1c17": {
"match": "brand_token",
"title": "TRESIBA (INSULIN DEGLUDEC) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS]",
"spl_version": "1",
"published_date": "2024-02-27"
}
},
"productid": "50090-7077_cc399f8e-7e57-48bd-993c-2104a4b1acf4",
"productndc": "50090-7077",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN DEGLUDEC",
"shortage_reason": "Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension",
"shortage_status": "current",
"proprietary_name": "TRESIBA",
"active_ingred_unit": "U/mL",
"application_number": "BLA203314",
"marketing_category": "BLA",
"nonproprietary_name": "insulin degludec",
"start_marketing_date": "20150925",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code A10AE06.
Access this data programmatically
Query TRESIBA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.